Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Return on Capital Employed (2016 - 2025)

Guided Therapeutics' Return on Capital Employed history spans 14 years, with the latest figure at 0.4% for Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 4.0% year-over-year to 0.4%; the TTM value through Sep 2025 reached 0.4%, down 4.0%, while the annual FY2024 figure was 0.46%, 105.0% down from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.4% at Guided Therapeutics, down from 0.42% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 4.27% in Q1 2023 and bottomed at 0.22% in Q1 2021.
  • The 5-year median for Return on Capital Employed is 0.59% (2022), against an average of 1.01%.
  • The largest annual shift saw Return on Capital Employed soared 368bps in 2023 before it crashed -348bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.62% in 2021, then surged by 329bps to 2.67% in 2022, then crashed by -57bps to 1.14% in 2023, then plummeted by -62bps to 0.44% in 2024, then decreased by -9bps to 0.4% in 2025.
  • Per Business Quant, the three most recent readings for GTHP's Return on Capital Employed are 0.4% (Q3 2025), 0.42% (Q2 2025), and 0.46% (Q1 2025).